pharmaceutical investing UroGen Pharma Submits Investigational New Drug (IND) Application for UGN-102 (VesiGel)
Torchlight Innovations (Doing Business as RZOLV Technologies) Announces Preliminary Positive Results on Rare Earth and Critical Mineral Recoveries